We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.99%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$110B
AUM Growth
+$11.3B
(+11%)
Cap. Flow
+$8.89B
Cap. Flow
% of AUM
8.09%
Top 10 Holdings %
Top 10 Hldgs %
35.27%
Holding
3,643
New
809
Increased
972
Reduced
1,047
Closed
744
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.35B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$2.85B |
| 3 |
Eli Lilly
LLY
|
+$999M |
| 4 |
Coca-Cola
KO
|
+$685M |
| 5 |
Broadcom
AVGO
|
+$616M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.38B |
| 2 |
Apple
AAPL
|
+$1.12B |
| 3 |
Netflix
NFLX
|
+$678M |
| 4 |
Boston Scientific
BSX
|
+$671M |
| 5 |
Cencora
COR
|
+$627M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Consumer Discretionary | 12.77% |
| 3 | Healthcare | 10.45% |
| 4 | Financials | 7.74% |
| 5 | Communication Services | 5.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Pagaya Technologies
PGY
$1.78B
| $15.5M | 0.01% |
742,072
+70,064
| +10% | +$1.78M |
|
702
Lantheus
LNTH
$6.59B
| $15.5M | 0.01% |
232,677
+197,905
| +569% | +$11.5M |
|
703
Heritage Insurance Holdings
HRTG
$991M
| $15.4M | 0.01% |
527,479
-496,878
| -49% | -$13.4M |
|
704
Relmada Therapeutics
RLMD
$527M
| $15.4M | 0.01% |
3,189,662
+2,917,609
| +1,072% | +$9.78M |
|
705
Triumph Financial Inc
TFIN
$1.82B
| $15.4M | 0.01% |
245,460
+35,626
| +17% | +$2M |
|
|
RNAM
706
DELISTED
Avidity Biosciences
RNAM
| $15.3M | 0.01% |
212,581
-427,003
| -67% | -$27.6M |
|
707
Royalty Pharma
RPRX
$25.3B
| $15.3M | 0.01% |
396,738
-1,086,938
| -73% | -$41.4M |
|
708
Equinox Gold
EQX
$13.5B
| $15.3M | 0.01% |
+1,089,074
| New | +$13.7M |
|
709
Brinker International
EAT
$9.66B
| $15.3M | 0.01% |
106,492
-230,604
| -68% | -$30.2M |
|
710
Calumet Specialty Products
CLMT
$3.44B
| $15.3M | 0.01% |
767,830
-123,560
| -14% | -$2.38M |
|
711
Yum China
YUMC
$16.3B
| $15.2M | 0.01% |
320,658
-126,387
| -28% | -$5.79M |
|
712
Strategy Inc
MSTR
$38.4B
| $15.2M | 0.01% |
100,000
+98,797
| +8,213% | +$22.7M |
|
713
Clean Harbors
CLH
$16.3B
| $15.1M | 0.01% |
64,581
+61,451
| +1,963% | +$14M |
|
714
Ironwood Pharmaceuticals
IRWD
$714M
| $14.9M | 0.01% |
4,424,002
+1,279,863
| +41% | +$3.32M |
|
715
Golar LNG
GLNG
$5.13B
| $14.9M | 0.01% |
400,389
+186,470
| +87% | +$7.13M |
|
716
Oscar Health
OSCR
$8.61B
| $14.9M | 0.01% |
1,035,145
-102,694
| -9% | -$1.78M |
|
717
CALL
Goldman Sachs
GS
$303B
| $14.9M | 0.01% |
+16,900
| New | +$13.8M |
|
718
FS KKR Capital
FSK
$3.44B
| $14.8M | 0.01% |
+1,002,150
| New | +$15.2M |
|
719
Energy Vault
NRGV
$633M
| $14.7M | 0.01% |
3,194,205
+1,821,462
| +133% | +$6.97M |
|
720
Kimco Realty
KIM
$16.4B
| $14.6M | 0.01% |
721,693
-1,178,435
| -62% | -$24.5M |
|
721
Establishment Labs
ESTA
$2.28B
| $14.5M | 0.01% |
198,374
+62,362
| +46% | +$3.77M |
|
722
Blue Bird Corp
BLBD
$2.18B
| $14.4M | 0.01% |
306,370
-118,844
| -28% | -$6.21M |
|
723
First Trust Dow Jones Internet Index Fund ETF
FDN
$5.34B
| $14.4M | 0.01% |
+53,326
| New | +$14.6M |
|
724
Levi Strauss
LEVI
$9.39B
| $14.3M | 0.01% |
689,029
-985,545
| -59% | -$21.2M |
|
725
Innovative Solutions & Support
ISSC
$361M
| $14.3M | 0.01% |
754,488
+275,286
| +57% | +$3.14M |
|
Similar funds
Marshall Wace's Q4 2025 Portfolio in Review
As of Q4 2025, Marshall Wace held 3,643 positions worth $110B, up 11% from $98.6B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Marshall Wace deployed $8.89B of net new capital in Q4 2025, opening 809 new positions and adding to 972 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Microsoft, an estimated $1.38B trimmed.
- Marshall Wace's largest Q4 2025 buy was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $3.35B increase.
- Marshall Wace's biggest Q4 2025 reduction was Microsoft, cutting an estimated $1.38B.
- Marshall Wace fully exited Ares Management in Q4 2025, selling an estimated $146M.
- Marshall Wace's ten largest holdings make up 35% of its $110B portfolio in Q4 2025.
- Marshall Wace opened 809 new positions and closed 744 in Q4 2025.
- Marshall Wace's portfolio value rose 11% quarter-over-quarter to $110B.
Based on Marshall Wace's 13F filing for Q4 2025, filed 13 Feb 2026.